14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 02, 2024 Sell 1 357 Swartz Robin Common Stock
Apr 02, 2024 Sell 12 115 Sandrock Alfred Common Stock
Apr 01, 2024 Buy 105 000 Ferguson Toby Common Stock
Mar 25, 2024 Buy 210 000 Ferguson Toby Stock Option (Right to Buy)
Mar 25, 2024 Buy 0 Ferguson Toby
Feb 21, 2024 Sell 3 966 Swartz Robin Common Stock
Feb 21, 2024 Sell 13 033 Sandrock Alfred Common Stock
Feb 21, 2024 Sell 3 764 Pfreundschuh Peter P. Common Stock
Feb 21, 2024 Sell 3 365 Carter Todd Alfred Common Stock
Feb 20, 2024 Sell 602 Carter Todd Alfred Common Stock
Feb 09, 2024 Buy 31 000 Fahey Sandell Jacquelyn Common Stock
Feb 09, 2024 Buy 62 000 Fahey Sandell Jacquelyn Stock Option (Right to Buy)
Feb 09, 2024 Buy 38 500 Carter Todd Alfred Common Stock
Feb 09, 2024 Buy 77 000 Carter Todd Alfred Stock Option (Right to Buy)
Feb 09, 2024 Buy 50 000 Swartz Robin Common Stock
Feb 09, 2024 Buy 100 000 Swartz Robin Stock Option (Right to Buy)
Feb 09, 2024 Buy 130 000 Sandrock Alfred Common Stock
Feb 09, 2024 Buy 260 000 Sandrock Alfred Stock Option (Right to Buy)
Feb 09, 2024 Buy 30 000 Pfreundschuh Peter P. Common Stock
Feb 09, 2024 Buy 60 000 Pfreundschuh Peter P. Stock Option (Right to Buy)
Jan 17, 2024 Sell 2 543 Swartz Robin Common Stock
Jan 17, 2024 Sell 1 266 Carter Todd Alfred Common Stock
Oct 03, 2023 Sell 13 567 Pfreundschuh Peter P. Common Stock
Oct 01, 2023 Buy 61 000 Fahey Sandell Jacquelyn Common Stock
Sep 15, 2023 Buy 5 000 Carter Todd Alfred Common Stock
Sep 15, 2023 Sell 10 500 Carter Todd Alfred Common Stock
Sep 15, 2023 Sell 5 000 Carter Todd Alfred Stock Option (Right to Buy)
Jul 10, 2023 Buy 122 000 Fahey Sandell Jacquelyn Stock Option (Right to Buy)
Jul 10, 2023 Buy 0 Fahey Sandell Jacquelyn
Jul 06, 2023 Sell 5 500 Carter Todd Alfred Common Stock
Jun 30, 2023 Buy 5 000 Carter Todd Alfred Common Stock
Jun 30, 2023 Sell 5 000 Carter Todd Alfred Common Stock
Jun 30, 2023 Sell 5 000 Carter Todd Alfred Stock Option (Right to Buy)
Jun 06, 2023 Buy 22 000 Pierce Glenn Stock Option (Right to Buy)
Jun 06, 2023 Buy 22 000 Mackey Catherine J Stock Option (Right to Buy)
Jun 06, 2023 Buy 22 000 Vitale Nancy Stock Option (Right to Buy)
Jun 06, 2023 Buy 22 000 Onyia Jude Stock Option (Right to Buy)
Jun 06, 2023 Buy 22 000 Higgins Michael J Stock Option (Right to Buy)
Jun 06, 2023 Buy 22 000 Colon Grace Stock Option (Right to Buy)
Jun 06, 2023 Buy 22 000 Geraghty James A Stock Option (Right to Buy)
Jun 06, 2023 Buy 22 000 Scangos George A Stock Option (Right to Buy)
Jun 06, 2023 Buy 22 000 Hyman Steven Stock Option (Right to Buy)
May 09, 2023 Buy 44 000 Scangos George A Stock Option (Right to Buy)
May 09, 2023 Buy 0 Scangos George A
Apr 03, 2023 Sell 7 437 Sandrock Alfred Common Stock
Apr 03, 2023 Sell 1 259 Swartz Robin Common Stock
Mar 15, 2023 Sell 15 373 Swartz Robin Common Stock
Feb 23, 2023 Buy 44 000 Onyia Jude Stock Option (Right to Buy)
Feb 23, 2023 Buy 0 Onyia Jude Common Stock
Feb 23, 2023 Buy 4 395 588 Neurocrine Biosciences Inc Common Stock
Feb 17, 2023 Sell 3 297 Hesslein Robert W. Common Stock
Feb 17, 2023 Buy 34 000 Carter Todd Alfred Common Stock
Feb 17, 2023 Buy 68 000 Carter Todd Alfred Stock Option (Right to Buy)
Feb 17, 2023 Sell 738 Carter Todd Alfred Common Stock
Feb 17, 2023 Buy 38 000 Pfreundschuh Peter P. Common Stock
Feb 17, 2023 Buy 76 000 Pfreundschuh Peter P. Stock Option (Right to Buy)
Feb 17, 2023 Buy 40 000 Swartz Robin Common Stock
Feb 17, 2023 Buy 80 000 Swartz Robin Stock Option (Right to Buy)
Feb 17, 2023 Buy 240 000 Sandrock Alfred Stock Option (Right to Buy)
Feb 17, 2023 Buy 120 000 Sandrock Alfred Common Stock
Feb 13, 2023 Sell 797 Carter Todd Alfred Common Stock
Feb 13, 2023 Sell 2 868 Hesslein Robert W. Common Stock
Feb 02, 2023 Sell 1 500 000 Third Rock Ventures Iii, L.p. Common Stock
Feb 01, 2023 Sell 128 642 Third Rock Ventures Iii, L.p. Common Stock
Jan 31, 2023 Sell 185 000 Third Rock Ventures Iii, L.p. Common Stock
Jan 30, 2023 Sell 75 000 Third Rock Ventures Iii, L.p. Common Stock
Jan 27, 2023 Sell 50 000 Third Rock Ventures Iii, L.p. Common Stock
Jan 25, 2023 Sell 50 000 Third Rock Ventures Iii, L.p. Common Stock
Jan 24, 2023 Sell 100 000 Third Rock Ventures Iii, L.p. Common Stock
Jan 23, 2023 Sell 55 000 Third Rock Ventures Iii, L.p. Common Stock
Jan 20, 2023 Sell 100 000 Third Rock Ventures Iii, L.p. Common Stock
Jan 17, 2023 Sell 1 396 Hesslein Robert W. Common Stock
Jan 17, 2023 Sell 792 Hesslein Robert W. Common Stock
Jan 17, 2023 Sell 706 Carter Todd Alfred Common Stock
Jan 17, 2023 Sell 400 Carter Todd Alfred Common Stock
Jan 17, 2023 Sell 1 396 Swartz Robin Common Stock
Jan 17, 2023 Sell 792 Swartz Robin Common Stock
Jan 11, 2023 Sell 110 000 Ecor1 Capital, Llc Common Stock
Jan 10, 2023 Sell 336 400 Ecor1 Capital, Llc Common Stock
Jan 09, 2023 Sell 456 000 Ecor1 Capital, Llc Common Stock
Jan 06, 2023 Sell 388 Carter Todd Alfred Common Stock
Jan 01, 2023 Buy 44 000 Colon Grace Stock Option (Right to Buy)
Jan 01, 2023 Buy 0 Colon Grace
Jan 01, 2023 Buy 0 Colon Grace
Dec 31, 2022 Buy 388 Carter Todd Alfred Common Stock
Oct 01, 2022 Buy 125 000 Pfreundschuh Peter P. Common Stock
Aug 24, 2022 Sell 200 000 Tepper Robert I Common Stock
Aug 16, 2022 Sell 128 456 Tepper Robert I Common Stock
Aug 15, 2022 Buy 44 000 Mackey Catherine J Stock Option (Right to Buy)
Aug 15, 2022 Buy 44 000 Mackey Catherine J Stock Option (Right to Buy)
Aug 15, 2022 Buy 0 Mackey Catherine J
Aug 12, 2022 Sell 135 808 Tepper Robert I Common Stock
Jul 14, 2022 Sell 9 512 Pierce Glenn Common Stock
Jul 14, 2022 Sell 13 891 Higgins Michael J Common Stock
Jun 21, 2022 Buy 376 000 Ecor1 Capital, Llc Common Stock
Jun 21, 2022 Buy 101 400 Ecor1 Capital, Llc Common Stock
Jun 06, 2022 Buy 22 000 Geraghty James A Stock Option (Right to Buy)
Jun 06, 2022 Buy 22 000 Geraghty James A Stock Option (Right to Buy)
Jun 06, 2022 Buy 22 000 Hyman Steven Stock Option (Right to Buy)
Jun 06, 2022 Buy 22 000 Higgins Michael J Stock Option (Right to Buy)
INSIDER POWER
42.654
Last 100 transactions
Buy: 7 546 876 | Sell: 3 757 926 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 42.654.

In total, the insiders bought 7 546 876 and sold 3 757 926 VYGR shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Voyager Therapeutics

Voyager Therapeutics Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau... VYGR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT